PVR and neoplasm: Similarly, T cell immunoglobulin and ITIM domains (TIGIT) on T cells can engage CD155 expressed on tumor cells and APCs to recruit SH2-containing inositol phosphatase-1 (SHIP1) to inhibit T cell signaling and activation (Liu et al., 2021).